Form 4 for EW Edwards Lifesciences
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-11 · accession 0001225208-24-004035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $36.75 | +14.4K | 188.0K | +8% | +$529.2K |
| D | 2024-03-11 | 2024-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $91.68 | -14.4K | 173.6K | -8% | -$1.32M |
| D | 2024-03-11 | 2024-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $0.00 | -14.4K | 28.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | M | A | 14,400 | $36.75 | 187,983.78 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-11 | S | D | 14,400 | $91.68 | 173,583.78 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $91.4500 to $92.0075. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2024-03-11 | M | D | 14,400 | $0.00 | 28,800 | D | $36.75 · 2018-05-11 to 2024-05-10 | 14,400 Common Stock |